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ABSTRACT
Human thymine-DNA glycosylase (TDG) is well
known to excise thymine and uracil from G´T and
G´U mismatches, respectively, and was therefore
proposed to play a central role in the cellular
defense against genetic mutation through spon-
taneous deamination of 5-methylcytosine and cyto-
sine. In this study, we characterized two newly
discovered orthologs of TDG, the Drosophila
melanogaster Thd1p and the Schizosaccharomyces
pombe Thp1p proteins, with an objective to address
the function of this subfamily of uracil-DNA
glycosylases from an evolutionary perspective.
A systematic biochemical comparison of both
enzymes with human TDG revealed a number of
biologically signi®cant facts. (i) All eukaryotic TDG
orthologs have broad and species-speci®c substrate
spectra that include a variety of damaged pyrimidine
and purine bases; (ii) the common most ef®ciently
processed substrates of all are uracil and 3,N4-
ethenocytosine opposite guanine and 5-¯uorouracil
in any double-stranded DNA context; (iii) 5-methyl-
cytosine and thymine derivatives are processed with
an appreciable ef®ciency only by the human and the
Drosophila enzymes; (iv) none of the proteins is
able to hydrolyze a non-damaged 5¢-methylcytosine
opposite G; and (v) the double strand and mismatch
dependency of the enzymes varies with the sub-
strate and is not a stringent feature of this subfamily
of DNA glycosylases. These ®ndings advance our
current view on the role of TDG proteins and docu-
ment that they have evolved with high structural
¯exibility to counter a broad range of DNA base
damage in accordance with the speci®c needs of
individual species.
INTRODUCTION
The human thymine-DNA glycosylase (TDG) was ®rst
discovered as an enzymatic activity in extracts of HeLa cells
that excised thymine from G´T mismatched oligonucleotide
DNA duplexes (reviewed in 1). Today, we know that this
DNA repair enzyme belongs to a large family of conserved
and omnipresent proteins with a common a/b-fold structure
and a general ability to excise uracil from DNA (2). All these
uracil-DNA glycosylases (UDGs) have a monofunctional
mode of action. They all employ a common base-¯ipping,
DNA intercalation strategy for substrate recognition and
binding, and catalyze the hydrolysis of the N-glycosidic bond
of the ¯ipped-out substrate base, thereby generating an abasic
site (AP-site) in the DNA backbone (reviewed in 3). However,
minor variations in the active site architecture and the catalytic
mechanism de®ne a number of subfamilies of UDGs with
distinct properties. The eukaryotic UDGs belong to the UNG,
MUG and SMUG subfamilies (2), with TDG representing
the founding member of the MUG branch. Most, if not all,
organisms possess at least one DNA uracil-processing
activity, but none of the UDG subfamilies is represented
ubiquitously. The UNG and MUG proteins show the broadest
distribution and are found in species ranging from bacteria to
human, whereas SMUG proteins appear to occur only in
multicellular eukaryotes excluding plants and nematodes (2).
Strikingly, Drosophila melanogaster lacks an UNG but
has a MUG and a SMUG, whereas the budding yeast
Saccharomyces cerevisiae has an UNG but neither a MUG
nor a SMUG, and the ®ssion yeast Schizosaccharomyces
pombe has both an UNG and a MUG, but no SMUG. The
enzymatic differences between the UDG protein subfamilies
are best illustrated by a comparison of UNG with TDG. Unlike
the very potent UNG-type UDGs that remove uracil from
single-stranded (ss) and double-stranded DNA (dsDNA) with
a high catalytic rate and selectivity (4), TDG processes both
uracil and thymine with an appreciable rate but only when
they are in a mispairing con®guration with guanine (5,6).
Since both the G´U and the G´T mismatches arise in DNA
mainly as a consequence of spontaneous hydrolytic deamina-
tion of cytosine or 5-methylcytosine, respectively, the G
mismatch dependence was taken as evidence for TDG being
responsible for the initiation of base excision repair (BER) at
sites of cytosine or 5-methylcytosine deamination in DNA.
The ®rst TDG homologs to be described were proteins of
Escherichia coli and Serratia marcescens that share ~37%
amino acid sequence identity with the human TDG and align
with its catalytic core domain (7). The in vitro translated E.coli
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enzyme showed UDG activity on a G´U substrate but failed to
process a G´T mismatch under physiological conditions. Like
human TDG, the bacterial protein did not excise uracil from
A´U base pairs or ssDNA ef®ciently and was therefore
named Mug (for mismatch-speci®c uracil-DNA glycosylase).
Mutational analysis of the human enzyme con®rmed that its
conserved central domain (residues 112±360) is indeed
suf®cient for processing of a G´U substrate, while ef®cient
hydrolysis of thymine from a G´T mismatch requires addi-
tional N-terminal sequence (6,7). Further insight into the
substrate spectra and requirements of the MUG subfamily of
UDGs came with the observation that both the human and the
E.coli enzymes were capable of excising the 3,N4-etheno-
cytosine (eC) from DNA (8). In fact, Mug was reported to
be the major activity in E.coli to eliminate this highly
mutagenic lesion from DNA (9). Other substrates described
for the human TDG were the cytotoxic anti-cancer agent
5-¯uorouracil (6) and 5-methylcytosine (10).
These ®ndings raise the question of whether MUG proteins,
rather than dealing speci®cally with the deamination products
of cytosine or 5-methylcytosine, are more generally involved
in the repair of DNA base damage. The crystal structure
available for E.coli Mug shows that, in principle, this is
possible. Unlike the restricting active site geometry of the
highly uracil-speci®c UNG proteins, the active site pocket of
Mug would easily accommodate a wide spectrum of
pyrimidine derivatives (11,12) and, owing to the high degree
of structural conservation, this is likely to be the case also for
other members of the protein subfamily. Thus, a systematic
examination of the substrate spectra of MUG proteins of
different species seems imperative for a comprehensive
understanding of their conserved functions and, ultimately,
their biological roles. This study introduces two novel
members of the MUG protein family, which we identi®ed in
the partially sequenced genomes of D.melanogaster and
S.pombe (1). We report their molecular cloning and bio-
chemical characterization, and show a systematic comparison
of the substrate spectra and requirements of the ®ssion yeast
and insect enzymes with those of the human TDG. The data
establish that eukaryotic MUG proteins have divergent
substrate spectra which include a wide range of damaged
cytosine, 5-methylcytosine, thymine and even adenine bases.
The G´U mismatch is the common most ef®ciently processed
substrate, whereas 5-methylcytosine and thymine derivatives
are processed at a physiologically relevant rate only by the
human enzyme. Also, the characteristic double strand and
mismatch dependency of the MUG proteins varies with the
substrate and is not strictly conserved between species.
These ®ndings suggest that MUG proteins have evolved
with a high degree of ¯exibility to counter particular forms of
DNA base damage according to the speci®c needs of
individual species.
MATERIALS AND METHODS
Reagents and oligonucleotides
All standard oligonucleotides were synthesized by Microsynth
(Switzerland). The oligonucleotides containing eC and HmU
were supplied by Gemini Biotech (USA). All substrate
oligonucleotides were puri®ed by PAGE after synthesis. All
enzymes were supplied by New England Biolabs (USA). All
other chemicals and reagents were purchased from Sigma
(Switzerland).
Plasmids and expression vectors
pPRS270. An NheI±SalI PCR fragment of the full-length
cDNA coding for S.pombe Thp1p was cloned into the
respective restriction sites of the plasmid pET28c from
Novagen (PCR primers were Thp1-NheATG, 5¢-CGATCG-
GCTAGCATGAACGACATTGAGACGA; and Thp1-TAA-
Sal, 5¢-TCCGTGTCGACTTAGACTGCATGTTTCAC).
pPRS250. A 1242 bp segment of the Drosophila Thd1 cDNA
encoding amino acids 650M±1063N of Thd1p was cloned as
a BglII±SalI PCR fragment into the BamHI±SalI restriction
sites of plasmid pQE30 (Qiagen) (PCR primers were Thd1-
BglATG, 5¢-GTACAGATCTATGCATTCACCATCACA-
TCG; and Thd1-TAGSal, 5¢-CCGACGTCGACCTAATTAT-
GATTAGACACTGGGAG).
pPRS125. pET28c (Novagen) containing an NheI±SalI PCR
fragment of full-length cDNA encoding the human AP
endonulease (APE1) cloned into the respective restriction
sites (PCR primers were APE1-NheATG, 5¢-CGATCGG-
CTAGCATGCCGAAGCGTGGGAAAAAG-3¢; and APE1-
TGASal, 5¢-TCCGTGTCGACTCACAGTGCTAGGTAT-
AGG-3¢).
These cloning strategies generated fusion open reading
frames (ORFs) encoding His6-Thp1p, His6-Thd1p (residues
650M±1063N) and His6-APE1, respectively, downstream of a
promoter±operator element consisting of phage T7 promoter
and a lac operator sequence.
Puri®cation of recombinant proteins
pPRS270 expressing S.pombe Thp1p was transformed into
E.coli BL21 (DE3) cells by electroporation, and transformants
were selected on LB plates containing 50 mg/ml kanamycin
and 2% glucose. Expression cultures of 2 l of LB medium
containing 50 mg/ml kanamycin were inoculated with 50 ml of
an overnight culture and incubated at 30°C to an OD600 of 1.2.
Following induction of protein expression by the addition of
isopropyl-b-D-thiogalactopyranoside (IPTG; to 500 mM) and
further incubation at 30°C for 3 h, the cells were harvested by
centrifugation (Sorvall SLA-3000, 6000 r.p.m., 4°C, 30 min)
and subsequently stored at ±80°C. For protein extraction,
thawed cell pellets were resuspended in 3 ml/g sonication
buffer (sb) [50 mM Na-phosphate pH 8.0, 300 mM NaCl, 10%
glycerol, 1 mM imidazole, 10 mM b-mercaptoethanol, 1 mM
phenylmethylsulfonyl ¯uoride (PMSF)] and lysed by sonic-
ation on ice (25 3 10 s bursts with intermittent chilling for
10 s). After removal of cell debris by centrifugation (Sorvall
SS34, 15 000 r.p.m., 4°C, 30 min), 1 ml of sb-equilibrated Ni-
NTA±agarose (Qiagen) was added to the crude lysate and
incubated for 1 h at 4°C with gentle shaking. The suspension
was then packed into a disposable column from which
unbound protein was washed out with 2 3 15 column
volumes (cv) of sb and 2 3 5 cv of sb containing 20 mM
imidazole. Finally, bound His6-tagged Thp1p was eluted with
5 3 1 cv of sb containing 300 mM imidazole. The 300 mM
imidazole fractions were pooled and diluted 1:3 with
dilution buffer (50 mM Tris±HCl pH 8.0, 10% glycerol,
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5 mM b-mercaptoethanol) resulting in an NaCl concentration
of 100 mM. After loading the diluted fraction onto a binding
buffer-equilibrated (50 mM Tris±HCl pH 8.0, 10% glycerol,
5 mM b-mercaptoethanol, 100 mM NaCl) 1.3 ml UNO S1
FPLC column (Bio-Rad) and washing with 10 ml of binding
buffer, bound protein was eluted with a linear gradient of
100±500 mM NaCl in 20 ml. The nearly homogeneous
S.pombe Thp1p (>98% pure) eluted as a major protein peak in
fractions containing ~300 mM NaCl. After a last dialysis step
against storage buffer (50 mM Tris±HCl pH 8.0, 50 mM NaCl,
10% glycerol, 5 mM b-mercaptoethanol), the pure Thp1p was
stored in aliquots at ±80°C.
pPRS250 expressing Drosophila His6-Thd1p was co-
transformed with the lacI-repressor encoding pREP4 plasmid
(Qiagen) into E.coli BL21 (DE3) cells by electroporation.
Transformants were selected on LB plates containing
100 mg/ml ampicillin, 50 mg/ml kanamycin and 2% glucose
after incubation at 30°C. Protein expression was done using
the induction and growth regimen described for human TDG
(6). Cell lysis and puri®cation on Ni-NTA±agarose were
performed as described above for Thp1p. All 300 mM
imidazole elution fractions were pooled, dialyzed extensively
against binding buffer (50 mM Tris±HCl pH 7.5, 10%
glycerol, 5 mM b-mercaptoethanol) and loaded onto an
equilibrated 1.3 ml UNO S1 FPLC column (Bio-Rad). After
washing with 10 ml of binding buffer, bound protein was
eluted with a linear gradient of 0±500 mM NaCl in 25 ml.
Thd1p eluted as a major protein peak in fractions containing
~300 mM NaCl, and the nearly homogeneous (>90% pure)
protein was dialyzed against storage buffer and stored in
aliquots at ±80°C.
Recombinant human His6-TDG was expressed in E.coli and
puri®ed as described before (6).
The expression construct for APE1 was transformed into
E.coli BL21 (DE3) cells and expression was achieved under
the same conditions as described above for Thp1p. The only
differences were the use of 1 l of expression culture and
induction at OD600 of 0.8. Cell lysis and puri®cation on Ni-
NTA±agarose were performed essentially as described for
Thp1p, with slightly different wash conditions using sb with
the following imidazole concentrations: 1 3 15 cv, 1 mM
imidazole; 5 3 5 cv, 20 mM imidazole; 1 3 5 cv, 60 mM
imidazole. Bound histidine-tagged APE1 protein was eluted
with 5 3 1 cv of sb containing 300 mM imidazole. All elution
fractions were pooled, dialyzed extensively against binding
buffer (50 mM Tris±HCl pH 8.0, 10% glycerol, 5 mM b-
mercaptoethanol) and loaded onto an equilibrated 1.3 ml UNO
S1 FPLC column (Bio-Rad). After washing with 10 ml of
binding buffer, bound protein was eluted with a linear gradient
of 0±500 mM NaCl in 15 ml. APE1 eluted as a major protein
peak in fractions containing ~350 mM NaCl, and the nearly
homogeneous (>97% pure) protein was dialyzed against
storage buffer and stored in aliquots at ±80°C.
Glycosylase activity assay
The enzymatic activities of the recombinant S.pombe Thp1p,
D.melanogaster Thd1p and human TDG proteins were
measured by means of a standardized nicking assay essentially
as described before (6). The oligonucleotide substrates used
are illustrated in Figure 2 and described in Hardeland et al. (6).
The nicking reactions were carried out in a total volume of
20 ml of 13 nicking buffer [50 mM Tris±HCl pH 8.0, 1 mM
dithiothreitol (DTT), 0.1 mg/ml bovine serum albumin (BSA),
1 mM EDTA, 0.5 U of uracil-DNA glycosylase inhibitor
(Ugi)] containing 1 pmol of substrate DNA and 1 pmol of
either of the recombinant proteins. Unless indicated otherwise,
the reactions were incubated for 15 min at 37°C and then
stopped by addition of 1 M NaOH to a ®nal concentration of
90 mM, heating to 99°C for 10 min and subsequent ethanol
precipitation. APE1-mediated cleavage of AP-sites was
assayed by the addition of 5 pmol of human APE1 and 5 mM
MgCl2, and incubation for 5 min at 37°C, followed by ethanol
precipitation. After ethanol precipitation, the dried pellets
were resuspended in 10 ml of formamide gel loading buffer
(90% formamide, 13 TBE) containing 200 mM NaBH4 to
limit spontaneous cleavage of the AP-site. Finally, the reaction
products were separated on 15% denaturing polyacrylamide
gels after short heat denaturation for 1 min at 60°C.
In kinetic assays, the reactions were set up in a 200 ml
volume with the substrate and enzyme concentrations
described above. At the indicated time points, 20 ml samples
were withdrawn, stopped by NaOH and treated further as
described above. Due to the instability of eC under alkaline
conditions and heat treatment, the reaction products of
these substrates were cleaved by APE1 as follows. Ethanol-
precipitated DNA was dissolved in 10 ml of 10 mM Tris±HCl
pH 8.0 and the reaction performed in a total volume of 20 ml of
13 APE1 buffer (50 mM Tris±HCl pH 8.0, 1 mM DTT, 5 mM
MgCl2) containing 4 pmol of APE1. After incubation for
10 min at 37°C, the reactions were stopped by ethanol
precipitation and analyzed on 15% denaturing polyacrylamide
gels as described above.
Electrophoretic mobility shift assays (EMSAs)
EMSAs were performed essentially as described before for
human TDG (6). In standard EMSA, 5 pmol of Thp1p, or
4 pmol of Thd1p and TDG were incubated in 10 ml reaction
mixtures containing 1 pmol of labeled oligonucleotide
substrate, 10 pmol of unlabeled homoduplex competitor
DNA, 50 mM Tris±HCl pH 8.0, 1 mM DTT, 5% glycerol
and 1 mM EDTA. After 15 min at 37°C, the reactions were
loaded immediately onto 6% non-denaturing polyacrylamide
gels (Bio-Rad, Mini Protean II cell) in 0.53 TBE, and
electrophoresis was carried out for 50 min at 100 V at room
temperature.
RESULTS
TDG homologs of Drosophila melanogaster and
Schizosaccharomyces pombe
The genome sequences of D.melanogaster and S.pombe
revealed ORFs encoding homologs of human TDG. We
cloned the cDNAs and named the genes thd1 and thp1 for
TDG homolog of D.melanogaster and S.pombe, respectively.
Drosophila thd1 is located on chromosome IV and has four
introns, one of them located in the 5¢-untranslated region of the
mRNA. Strikingly, this gene encodes a large protein of 1738
amino acids with a calculated molecular mass of 191.5 kDa.
The S.pombe thp1 is an intron-less gene of chromosome III
and produces a protein of 325 amino acids with a molecular
mass of 36.5 kDa. mRNA analyses by northern blotting
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revealed transcripts of the thd1 and the thp1 genes in
proliferating Drosophila (Schneider S3) and in vegetatively
growing as well as meiotically differentiating ®ssion yeast
cells, respectively. Three thd1-speci®c signals were detect-
able, the predominant one being the shortest of ~6100
nucleotides (nt) length, matching the size of the cloned
cDNA, and the longer species most probably representing
differently spliced precursors. thp1-speci®c mRNA appeared
as a single band corresponding to a length of 1200 nt, which is
predicted from its genomic sequence (data not shown). Hence,
thd1 and thp1 are both expressed genes but they have never
been described genetically.
Phylogenetic analyses of Thd1p and Thp1p clearly associ-
ated both proteins with the MUG branch of UDGs (Fig. 1A),
and an amino acid sequence alignment of both with human
TDG and E.coli Mug (7) revealed a moderate degree of
conservation that is con®ned to the catalytic core domains of
the proteins (Fig. 1B). The core domains show the typical
signature of a/b-fold UDGs of the MUG type (2), including
the highly conserved active site motif, as inferred from
structural and biochemical analyses of the E.coli Mug (11) and
the human TDG proteins (6) (Fig. 1B). This GINPGL motif
has a minor variation in Thp1p where the isoleucine and the
leucine residues appear to be swapped to give a GLNPGI
sequence. The invariant asparagine within this motif (Asn140
in TDG; Asn18 in Mug) is critical for catalysis. It is proposed
to mediate hydrolysis of the N-glycosidic bond linking the
DNA base with the sugar moiety of the nucleoside by
positioning and activating a water molecule for a hydrophilic
attack (6,11). Asn795 and Asn158 occupy structurally
equivalent positions in Thd1p and Thp1p, respectively, and
are thus considered the putative active site residues of these
enzymes. A second, less conserved C-terminal sequence motif
(VMPSSSAR in TDG) also contributes to the active site in
MUG proteins. Residues of this motif were shown to establish
speci®c contacts with the DNA substrate during the base
hydrolysis process, ensuring both stability of the DNA helical
structure and substrate speci®city (6,11). Closely related
sequence elements are present at equivalent positions in
Thd1p (VMPSSSAR) and in Thp1p (VGISSSGR). Interest-
ingly, the extra N- and C-terminal domains of the eukaryotic
MUG proteins appear to be species speci®c and vary in
sequence composition and size (Fig. 1C). However, the
overall architecture and the speci®c structural elements of
the conserved domains imply that Thd1p and Thp1p are
MUG-type UDGs.
Recombinant Thd1p and Thp1p possess DNA
glycosylase activity
To facilitate enzymatic studies, we produced the Drosophila
and S.pombe TDG homologs in E.coli and puri®ed the
recombinant proteins to near homogeneity. In the case of the
large Thd1p, we engineered a vector expressing a segment of
415 amino acids (650M±1063N) including the putative
catalytic domain (see Fig. 1) plus an extra His6 tag at the
N-terminus. Thp1p was expressed as a full-length protein with
an N-terminal His6 tag. Both proteins were expressed in
soluble form in E.coli and, following a two-step puri®cation
scheme including Ni-NTA and FPLC-UNO S1 chromato-
graphy, we were able to recover 2±4 mg of highly pure protein
per liter of bacterial culture. Like human TDG (46 kDa), the
46 kDa Thd1p polypeptide showed a retarded mobility in
SDS±PAGE (~60 kDa), whereas migration of the 37 kDa
Thp1p was as expected (Fig. 2A).
Figure 1. Conservation of MUG-type UDGs. (A) Shown are the phylogenetic
relationships between representative UDGs of the a/b-fold superfamily.
Included are Homo sapiens UNG2 (hsUNG2; accession no. P22674),
TDG (hsTDG; Q13569) and SMUG1 (hsSMUG1; O95862); Drosophila
melanogaster Thd1p (dmThd1p; Q9V4D8) and SMUG1 (dmSMUG1;
Swiss-Prot, Q9VEM1); Xenopus laevis SMUG1 (xlSMUG1; Q9YGN6)
Schizosaccharomyces pombe Ung1p (spUng1p; O74834) and Thp1p
(spThp1p: O59825); Saccharomyces cerevisiae Ung1p (saccUng1p;
P12887); Serratia marcescens Mug (smMug; P43343); Escherichia coli
Ung (ecUng; P12295) and Mug (ecMug; P43342); Streptomyces coelicolor
UDGb (scUDGb; NP_626251) and MUG (scMug; NP_625542);
Pyrobaculum aerophilum UDGa (paUDGa; NP_558739) and UDGb
(paUDGb: NP_559226); Thermus thermophilus UDG (tthUDG;
CAD29337); Mycobacterium tuberculosis UDG (mtUDG; NP_335742);
Thermotoga maritima UDG (tmUDG; NP_228321); and Archaeoglobus
fulgidus UDG (afUDG; NP_071102). (B) Amino acid sequence alignment
of the catalytic core domains of spThp1p, dmThd1p with hsTDG and
ecMug. The conserved MUG characteristic active site motif G(I/L)NPG(L/
I) in the N-terminal part of the catalytic domain and the less conserved
C-terminal residues that are critical for a speci®c interaction with the sub-
strate DNA are framed in red; other conserved residues are framed and
shaded. The arrow indicates the position of the critical catalytic residue
(N140) of TDG (6). (C) Schematic representation of the overall domain
organization of the same members of the MUG subfamily of UDGs. The
conserved core domains of the proteins are shaded, and the relative
positions of the active site motifs indicated. All sequence analyses were
done with the ClustalW routine (Blosum30 matrix; Gap penalty, 10; Gap
extension penalty, 0.1) of the MacVector Sequence analysis software
(Version 7.1.1; Accelrys, Burlington, USA).
2264 Nucleic Acids Research, 2003, Vol. 31, No. 9
To monitor the catalytic activities of Thd1p and Thp1p, we
employed a standard base release assay previously developed
for human TDG (6). The assay measures the excision of
mispaired (e.g. G´U) and/or damaged (e.g. G´eC) DNA bases
from synthetic 60mer oligonucleotide duplex substrates
(Fig. 2B). Incubation of Thd1p and Thp1p alone with a G´U
substrate did not yield any incised product (Fig. 2C). Only
when the samples were incubated further with the human AP-
endonuclease APE1 or heat treated in the presence of 90 mM
NaOH did product bands with the expected length of 23 nt
appear on the gel. The slightly higher electrophoretic mobility
of the chemical cleavage products is accounted for by the
negatively charged 3¢ phosphate generated by the b,d-
elimination reaction involved. Neither APE1 nor NaOH
treatment alone generated any detectable incision products
(data not shown). These data illustrate that recombinant Thd1p
and Thp1p act as monofunctional DNA-glycosylases with
properties similar to the human TDG.
We further investigated the effects of temperature, pH and
possible cofactors on G´U processing by Thd1p and Thp1p.
Both enzymes were most active at 37°C with a pH between 7
and 9. Testing the requirement for divalent metal ions and
ATP revealed that neither of the combinations of Mg2+, Mn2+
or Fe2+ with ATP had any effect on the nicking activities of the
two enzymes. However, Zn2+ at concentrations >1 mM
inhibited the G´U processing activity of both enzymes as
well as of human TDG. Therefore, we chose a metal ion- and
ATP-free buffer at pH 8.0 and an incubation temperature of
37°C for all subsequent comparisons.
TDG homologs all process uracil in DNA but act
differently on G´T mispairs
The human TDG excises thymine from G´T and uracil from
G´U mismatched substrates (13,14), whereas the E.coli Mug
protein processes G´U substrate but fails to act on G´T
mismatches with an appreciable ef®ciency (7). To compare
the substrate preferences of the eukaryotic MUG proteins, we
examined their abilities to process the `classical' G´T, G´U and
A´U substrates as well as U in ssDNA. While the G´U mispair
was ef®ciently converted to product G´AP-sites by all
enzymes, the G´T mismatch was only a poor substrate for
Thd1p and totally resisted processing by Thp1p (Fig. 3). Even
in the presence of high concentrations of Thp1p and after
extended incubation, the G´T substrate remained fully intact
Figure 3. Differential G´T processing by TDG, Thd1p and Thp1p. The
ability to generate alkaline-sensitive sites in standard substrates was assayed
for TDG (A), Thd1p (B) and Thp1p (C) in the absence or presence of 1 U
of Ugi. Shown are the results obtained with 60mer dsDNA substrates
containing either G´C, G´T, G´U or A´U base pairs or a single uracil in
ssDNA at identical positions. All reactions were done in a 20 ml volume
containing equimolar amounts (50 nM) of substrate DNA and enzyme, and
the products were separated on 15% denaturing polyacrylamide gels. The
positions of the 60mer substrate DNA and 23mer product fragment are
indicated.
Figure 2. Glycosylase activity of TDG, Thd1p and Thp1p. (A) Fractions of
puri®ed TDG, Thd1p and Thp1p analyzed by SDS±PAGE. A 2 mg aliquot
of each protein was loaded onto a 12.5% gel. The proteins were visualized
by Coomassie brilliant blue staining. (B) The 60mer oligonucleotide duplex
DNA used as substrate. An unlabeled upper strand oligonucleotide contains
guanine or adenine at the position indicated. The complementary 5¢-¯uores-
cein-labeled (green asterisk) lower strand positions either a cytosine, a
thymine, a uracil or any other target base of interest opposite the guanine as
indicated. AccI and SalI digestions result in 22mer and 23mer product
formation, respectively. (C) Thd1p and Thp1p generate APE1 and alkaline-
sensitive AP-sites in a G´U substrate. Standard base release reactions were
done in 20 ml volumes in the presence of 1 pmol of substrate DNA and
1 pmol of protein. The reaction products shown were analyzed on 15%
denaturing polyacrylamide gels. The positions of the 60mer substrate DNA,
the respective product fragments, and the 22mer and 23mer AccI and SalI
restriction fragments are indicated.
Nucleic Acids Research, 2003, Vol. 31, No. 9 2265
(data not shown). Strikingly, unlike the human and Drosophila
enzymes, Thp1p showed little preference for mismatched
substrate and processed uracil opposite A or in an ssDNA
context with remarkable ef®ciency.
All UNG-type UDGs are inhibited by the small polypeptide
Ugi encoded by the bacteriophage PBS2 (15). Although UNG
and MUG proteins appear to have similar active site archi-
tectures (11), E.coli Mug and human TDG are not inhibited by
Ugi (7), and this is also true for Thd1p and Thp1p (Fig. 3). All
substrates tested were processed to the same extent by both
enzymes in the absence or presence of an excess of Ugi
peptide (Fig. 3). Identical reaction conditions fully inhibited
an equimolar amount of the E.coli Ung enzyme (data not
shown).
The differences in substrate spectra and mismatch depend-
encies prompted us to investigate the base release reaction in
more detail. Because TDG is fully product inhibited owing to
its tight binding to the product AP-site (6,16,17), we used a
previously standardized method to measure and compare
single turnover kinetics of AP-site formation (6). Time course
experiments with TDG, Thd1p and Thp1p and G´U substrate
revealed that all reactions proceeded relatively quickly in an
initial phase, and then leveled off to a plateau where no more
substrate was processed (Fig. 4). We con®rmed that neither of
the enzymes lost activity under assay conditions and that the
product:enzyme ratios never exceeded 1:1 even when a vast
excess of substrate over enzyme was provided (data not
shown). Thus, the plateaus re¯ect product inhibition of Thd1p
and Thp1p.
As expected, the kinetic time courses with the substrates
G´T, A´U and U in ssDNA showed interesting qualitative
differences. G´T was processed with an intermediate ef®-
ciency by TDG, with low ef®ciency by Thd1p but not
detectably by Thp1p. The comparably slow initial rate of
Thd1p most probably re¯ects a poor af®nity of the protein for
the G´T mismatch so that initial mismatch binding would be
the rate-limiting step in this reaction. A poor af®nity for the
G´T mismatch was shown previously for human TDG (6) and
could also help to explain the lack of G´T processing by Thp1p
and E.coli Mug. On the other hand, A´U and U in ssDNA (ssU)
were processed with an appreciable rate by Thp1p only. The
reaction with A´U was initially slower but plateaued at a level
comparable with that obtained with G´U, whereas single-
stranded uracil substrate was processed with an intermediate
rate and to a higher product yield. Since Thp1p also failed to
turn over on these substrates (data not shown), we conclude
that the substrate-dependent uracil excision kinetics re¯ect
differences in enzyme±substrate complex formation rather
than in catalysis. The kinetic properties further show that
catalysis by Thp1p is less dependent on a speci®c interaction
with the base opposite uracil, implicating a catalytic mechan-
ism which differs from that proposed for the human and
bacterial proteins (6,11). Taken together, G´U appears to be a
common ef®ciently processed substrate for all MUG-type
UDGs but neither the G´T processing activity nor the mismatch
dependency of the proteins appear to be strictly conserved.
Comparison of DNA-binding properties of Thd1p,
Thp1p and TDG
The lack of turnover in base release assays with dsDNA
substrates indicated that Thd1p and Thp1p are strongly
product inhibited. We therefore examined the ability of the
two enzymes to bind different DNA substrates and product
AP-sites in the presence or the absence of homoduplex
competitor DNA. EMSAs in the presence of a 10-fold excess
of competitor DNA revealed that both enzymes bound G´C
homoduplex and G´T heteroduplex DNA with signi®cantly
lower af®nity than the G´U substrate (Fig. 5, lanes 1±3). This
Figure 4. Kinetic properties of Thd1p and Thp1p in comparison with TDG. The time-dependent generation of alkaline-sensitive AP-sites was measured by
incubation of TDG (A), Thd1p (B) and Thp1p (C) with double-stranded 60mer substrates containing either a single G´U, G´T or A´U mismatch, or ssDNA
containing U as indicated. The substrate and enzyme concentrations were 50 nM as described for the standard TDG assay (6). All reactions were performed
at 37°C and stopped after the indicated times by the addition of NaOH. Product formation was monitored and quanti®ed after denaturing gel electrophoresis
and ¯uorescent scanning. Shown are nicking ef®ciencies averaged from at least three independent experiments over short (upper panels) and longer (lower
panels) time courses; standard deviations are listed in Table 1.
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resembled the substrate-binding preferences of a catalytically
inactive variant of TDG (6). The apparently higher af®nity of
TDG for the G´T substrate re¯ects the ability of this enzyme
to process the mismatch under EMSA conditions (6, and
unpublished data), while Thd1p and Thp1p are unable to do so.
Hence, the assay measures product AP-site binding for TDG
but G´T binding for Thd1p and Thp1p. The same caveat of
substrate conversion also applies when binding of Thd1p and
Thp1p to the well processed G´U substrate is examined. The
®nding that both enzymes bound to G´U duplexes nearly as
robustly as to G´AP-site substrates (Fig. 5, lanes 3 and 4) must
therefore be interpreted to re¯ect their high compound
ef®ciencies of uracil excision and G´AP-site interaction. Of
all the enzymes, Thp1p was the only one to bind an A´U
substrate with an appreciable ef®ciency and an A´AP-site
duplex with a high af®nity (Fig. 5, lanes 5 and 6). This is
consistent with its ability to release uracil from A´U base pairs
in a reaction that is product AP-site inhibited (Fig. 4). In
contrast, Thd1p and TDG bound ef®ciently to G´AP sub-
strates whereas A´AP binding was hardly above homoduplex
background (Fig. 5, lanes 4 and 6).
These data document that the complementary base facing
the AP-site rather than the AP-site itself determines the DNA-
binding af®nities of MUG enzymes, and that this mode of
opposite base interaction may differ slightly between Thp1p
and Thd1p or TDG. For the reasons discussed above, a more
precise assessment of substrate af®nities is dif®cult with active
DNA glycosylases and will require the use of either non-
hydrolyzable DNA substrates (18), or of catalysis-de®cient
but substrate interaction-pro®cient mutant proteins (6).
Comparison of the substrate spectra of Thd1p, Thp1p
and human TDG
Unlike UNG proteins, which have a restricting active site
geometry designed for accommodation of and speci®c inter-
action with uracil (19), MUG proteins appear to form a
comparably loose binding pocket, where no speci®c contacts
with the substrate base are established (12). This observation
led us to investigate the substrate spectrum of the eukaryotic
MUG proteins in greater detail. We thus examined the abilities
of Thd1p, Thp1p and TDG to excise various DNA base lesions
including oxidation, alkylation and deamination products of
cytosine, 5-methylcytosine, thymine and adenine (Fig. 6).
Because these enzymes are fully product inhibited, we based
our comparisons on measurements of single turnover kinetics
under conditions that were standardized for TDG (6). For each
substrate, we determined the parameters Pmax, maximum of
substrate processing within an unlimited period of time; and
T50, the time required to reach 50% of the product plateau
level (Pmax) (6). To facilitate comparison, we calculated a
relative processing ef®ciency (EffRel) for each enzyme and
substrate by dividing Pmax by T50. The values obtained from at
least three independent measurements are listed in Table 1,
and the relative processing ef®ciencies for all double-stranded
substrates are plotted in Figure 7. Because the substrates
5-hydroxyuracil (HU) and 5-hydroxycytosine (HC) were
provided in a slightly different sequence context and required
an autoradiography-based method of evaluation, these results
are not directly comparable with all others and therefore are
only mentioned in the text.
With the exception of HC (not shown), human TDG
removed the substrate pyrimidines 5-¯uorouracil (FU),
5-hydroxymethyluracil (HmU), 5-bromouracil (BrU), eC and
thymine paired with guanine with high relative ef®ciencies
(Table 1, Fig. 7). HU mispaired with guanine was also excised
from DNA with a catalytic ef®ciency in the range of that
obtained for G´HmU (data not shown). In addition, TDG
ef®ciently excised eC opposite adenine and FU from any
dsDNA or ssDNA substrate as observed previously (6,8).
Remarkably, we also found a low but signi®cant level of
hypoxanthine (Hx) processing when the base was located
opposite guanine. Since Hx is the deamination product of
adenine, it would arise most frequently in DNA opposite
thymine, but TDG processed a Hx´T substrate with an
insigni®cant ef®ciency only. All data together give the
following order of substrate preference for TDG: high
ef®ciency, G´FU > G´U > G´HmU > G´HU > G´BrU > G´eC >
G´T = A´FU; intermediate ef®ciency, A´eC > G´Hx > A´U; low
ef®ciency, A´BrU = T´Hx; insigni®cant ef®ciency, G´eA =
T´eA = G´G > G´mC = G´HC (Table 1, Fig. 7).
Thd1p showed a substrate preference very similar to that of
TDG except that it was signi®cantly less effective (5±10-fold)
on the derivatives of 5-methylcytosine (G´HmU, G´T). Like
TDG, Thd1p clearly preferred guanine as an opposite base
and, with the notable exception of FU, did not process
damaged bases in ssDNA ef®ciently (Table 1, Fig. 7). Thd1p
Figure 5. Substrate and product DNA-binding properties. Comparative EMSAs were performed with TDG, Thd1p and Thp1p as indicated. The DNA-binding
reactions were performed in a 10 ml volume with 1 pmol of labeled homoduplex (G´C), substrate (G´T, G´U, A´U) or product DNA (G´AP, A´AP) in the
presence of 10 pmol of unlabeled homoduplex competitor DNA and either 4 pmol of TDG, 4 pmol of Drosophila Thd1p or 5 pmol of S.pombe Thp1p. The
AP-site-containing DNAs were generated by incubation of uracil substrate DNA with E.coli UDG and subsequent puri®cation as described (6). Bound
¯uorescein-labeled DNA was separated from free substrate DNA in 6% native polyacrylamide gels. Shown are ¯uorograms of representative gels.
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thus processes dsDNA substrates with the following prefer-
ence: high ef®ciency, G´FU > G´U > G´BrU > G´eC > G´HmU;
intermediate ef®ciency, A´FU > A´eC > G´T = G´Hx;
low ef®ciency, A´U > A´BrU = T´Hx; insigni®cant ef®ciency,
G´eA = T´eA = G´G > G´mC.
Thp1p was a surprise. This enzyme processed all substrates
containing U, FU, eC and HU irrespective of whether they were
in a dsDNA or a ssDNA context. Thp1p also excised the
purine derivatives Hx, 1,N6-ethenoadenine (eA) and even a
regular guanine in a G´G mismatch. However, the enzyme
showed no activity towards T, HmU or HC. In general, Thp1p
hydrolyzed the target base fastest when it was opposite a
guanine, but for most substrates the Pmax values reached
similar levels independent of the complementary base. Thp1p
Table 1. Relative substrate processing ef®ciencies of TDG, Thd1p and Thp1p
Substrate TDG Thd1p Thp1p
Pmax T50 Erel Pmax T50 Erel Pmax T50 Erel
G´U 68 6 2 0.9 76 78 6 3 1.2 65 73 6 3 0.8 91
A´U 35 6 1 40 0.9 27 6 1 60 0.5 70 6 4 2.0 35
ssU <5 >60 <0.08 <5 >60 <0.08 95 6 2 1.8 53
G´FU 90 6 2 0.6 150 83 6 2 0.9 92 80 6 3 0.5 160
A´FU 75 6 3 4.2 18 81 6 2 15 5.4 72 6 3 1.0 72
ssFU 95 6 2 9.2 10 93 6 1 20 4.7 96 6 1 0.7 137
G´BrU 68 6 2 1.5 45 66 6 2 2.0 33 73 6 1 13 5.6
A´BrU 17 6 1 55 0.3 <5 >60 <0.08 29 6 1 30 1.0
ssBrU <5 >60 <0.08 <2 >60 <0.02 73 6 1 14 5.2
G´T 45 6 2 2.2 20 56 6 4 40 1.4 <2 >60 <0.03
G´HmU 49 6 1 0.8 61 68 6 3 5.5 12 <2 >60 <0.03
G´eC 72 6 5 2.5 29 86 6 3 4.6 19 86 6 3 0.7 123
A´eC 55 6 2 9.1 6.0 72 6 3 15 4.8 83 6 5 0.9 82
sseC <5 >60 <0.08 <5 >60 <0.08 87 6 7 1.8 48
G´Hx 42 6 3 42 1.0 47 6 1 45 1.0 70 6 2 0.5 140
T´Hx <5 >60 <0.08 <5 >60 <0.08 71 6 4 0.5 142
ssHx <2 >60 <0.03 <2 >60 <0.03 92 6 2 0.3 307
G´eA <2 >60 <0.03 <2 >60 <0.03 65 6 2 3.8 17
T´eA <2 >60 <0.03 <2 >60 <0.03 68 6 1 3.6 19
sseA <2 >60 <0.03 <2 >60 <0.03 60 6 2 12 5.0
G´G <2 >60 <0.03 <2 >60 <0.03 54 6 1 42 1.3
G´mC <1 >60 <0.02 <1 >60 <0.03 <1 >60 <0.02
The generation of alkaline-sensitive sites was assessed by measurement of single turnover parameters under standardized reaction conditions. The substrate
and enzyme concentrations were 50 nM each and the reaction products were quanti®ed after denaturing gel electrophoresis and ¯uorescence scanning. Shown
are the plateau levels of substrate nicking (Pmax) and the time required for processing of 50% of Pmax (T50) for all enzymes with the respective substrates, as
indicated. Relative processing ef®ciency was calculated as: Erel = Pmax/T50.
Figure 6. Substrate DNA bases examined. Shown are the chemical structures of purine and pyrimidine DNA bases with modi®cations relevant to this study.
2268 Nucleic Acids Research, 2003, Vol. 31, No. 9
thus prefers dsDNA substrates in the order: high ef®ciency,
G´FU > T´Hx = G´Hx > G´eC > A´eC > A´FU > A´U > T´eA =
G´eA; intermediate ef®ciency, G´HU > G´BrU > G´G > A´BrU;
insigni®cant ef®ciency, G´T = G´HmU > G´mC (Table 1, Fig. 7).
The most impressive difference between the substrate
spectra of the three MUG proteins was the inability of Thp1p
to process the 5-methylcytosine-derived G´T and G´HmU
mispairs on the one hand, and its broader range of ef®ciently
processed substrates, including the adenine derivatives Hx and
eA and the G´G mismatch, on the other hand. Another obvious
difference was the lack of opposite base and/or dsDNA
dependency in the action of Thp1p on virtually all substrates
tested. The common, most ef®ciently processed substrates for
all enzymes were the cytosine-derived G´U, G´HU, G´eC and
A´eC mispairs as well as the non-physiological but therapeut-
ically interesting FU. Recent reports documented the excision
of 5-methylcytosine in a hemimethylated CpG sequence
context by bacterially expressed human and chicken TDG.
This activity was 30-fold lower than that of thymine excision
from G´T mismatches (10). Using different hemi- and
symmetrically methylated DNA substrates (mC´G/G´C,
mC´G/G´mC) and applying similar assay conditions, we were
unable to detect a release of mC by TDG or by either the
Drospophila or the S.pombe proteins. Finally, the DNA
sequence context only marginally affected the relative
ef®ciencies of uracil excision by all three enzymes (data not
shown).
DISCUSSION
In this study, we introduce two novel members of the MUG
family of DNA glycosylases, Thd1p of D.melanogaster and
Thp1p of S.pombe. A comparative enzymatic characterization
of the human, Drosophila and ®ssion yeast proteins justi®es
the following general conclusions: (i) eukaryotic MUG
proteins have divergent and species-speci®c substrate spectra
that include a wide range of damaged cytosine, 5-methyl-
cytosine, thymine and even adenine bases; (ii) the common,
most ef®ciently processed substrate is a G´U mismatch,
whereas 5-methylcytosine and thymine derivatives are pro-
cessed with a physiologically relevant rate only by the human
enzyme; and (iii) the double strand and mismatch dependency
of the MUG enzymes varies with the substrate and is not
strictly conserved between the species. These ®ndings open up
novel perspectives with regard to the possible biological roles
of MUG proteins and provide a solid basis for functional
studies in prominent genetic model organisms.
Like the bacterial and human orthologs, the Drosophila and
®ssion yeast MUG enzymes are monofunctional, they
hydrolyze the N-glycosidic bond of a target base without
incising the DNA strand at the resulting AP-site. The substrate
spectra of Thd1p and TDG appear to be similar, with the
caveat that the preferences of the full-length Thd1p may
deviate slightly from those of the extended glycosylase
domain studied here. Thp1p, however, shows some interesting
and distinctive features. It fails to process G´T and G´HmU but
ef®ciently excises damaged and/or mispaired purine bases,
and lacks dsDNA or opposite base dependency.
A lack of G´T and G´HmU processing is understandable from
the standpoint that S.pombe apparently does not methylate
cytosine in DNA (20). Obviously, this obviates the need for an
enzyme dealing with 5-methylcytosine damage. In organisms
that have cytosine methylation, however, evolution appears to
have selected for MUG proteins with an acquired function to
excise the respective deamination and oxidation products. In
this context, it is noteworthy that the domain architecture of
the MUG proteins documents a modular evolution that most
probably started from a simple DNA glycosylase fold to which
activities modulating N- and C-terminal sequences were
added in the process of adaptation to specialized functions. For
Figure 7. Substrate processing ability of eukaryotic MUG proteins. The substrate processing ef®ciencies of TDG, Thd1p and Thp1p were determined in
kinetic assays as described in the text. Each experiment was repeated at least three times, and the resulting Pmax, T50 and Effrel (= Pmax/T50) values are listed
in Table 1. Graphically illustrated are the relative processing ef®ciencies (Effrel) obtained with dsDNA substrates showing comparable kinetic properties. For
ease of comparison, the Effrel values are normalized to the relative ef®ciency of G´U processing for each individual enzyme [= Effrel(X´Y)/Effrel(G´U)].
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instance, the ability to process G´T or G´HmU ef®ciently
appears to be related to the structure of the non-conserved
N-termini of these proteins rather than to the geometry of their
active sites. Deletion of the N-terminus of TDG was shown to
virtually abolish G´T but not G´U processing activity, and
E.coli Mug that lacks a comparable N-terminus does not
process G´T mismatches with a physiologically signi®cant rate
(7). Also, the ability of MUG proteins to hydrolyze purine-
derived substrate bases (e.g. Hx and eA) implicates that bases
far bulkier than thymine can ®t into their active site pockets.
This suggests that the initial formation of a productive
enzyme±substrate complex and/or catalysis rather than a
steric exclusion of thymine from the binding pocket is rate
limiting for G´T processing by Thp1p and, by inference, by
E.coli Mug and the N-terminally truncated human TDG
protein. However, the resolution of exactly how the
N-terminus of TDG provides G´T processing ability will
require more detailed structure±function studies.
TDG and E.coli Mug show relatively low catalytic
ef®ciency as compared with the functionally related UNG
enzymes, and both need to establish a stable interaction with
the DNA strand opposite the mismatched substrate base
whereby speci®c opposite base contacts play an important role
(6,11,12). Interestingly, Thp1p shows little double strand or
complementary base dependency; similar to UNG enzymes,
but unlike TDG and Thd1p, it excised uracil from both dsDNA
and ssDNA substrates with comparable ef®ciencies. This is
consistent with the DNA-binding properties of the glycosyl-
ases; Thp1p could stably interact with a guanine and an
adenine opposite an AP-site, whereas the human and
Drosophila enzymes showed a strong preference for the
G´AP substrate and A´AP binding was only insigni®cantly
above homoduplex background. Thus, an increased af®nity for
a complementary adenine would give Thp1p the power to
interact stably with and process uracil in any DNA substrate
that has the potential to establish a secondary structure
involving the substrate base. Obviously, precisely this must be
avoided for thymine-processing MUG enzymes such as TDG
to ensure the discrimination between a regular thymine
opposite an adenine and a mutagenic thymine mispaired
with guanine, which prevents processing of normal A´T base
pairs.
Besides uracil and thymine, several other DNA lesions are
processed by MUG proteins. To date, we can distinguish
three classes of substrates: those that represent damaged
cytosine bases, including U, HU or eC; those that arise from
5-methylcytosine, namely T and HmU; and the purine deriva-
tives Hx and eA. However, uracil in a G´U mismatch and eC in
a G´eC context appear to be the only substrates processed
ef®ciently by all MUG enzymes tested to date. We would
therefore conclude that the conserved function of MUG DNA
glycosylases is the repair of cytosine damage in DNA.
In the absence of genetic evidence, the biological sig-
ni®cance of the divergent substrate spectra of the MUG
proteins remains uncertain. The range of possible substrates
predicts that the MUG proteins are functionally redundant
with other DNA glycosylases including UDGs and enzymes
that process oxidized pyrimidines (e.g. NTH1) and deamin-
ation or alkylation products of purines (e.g. MAG1).
Considering only the repair of cytosine or 5-methylcytosine
damage in mammalian cells, there are at least three enzymes
in addition to TDG that are capable of excising the respective
deamination and/or oxidation products: UNG is a very potent
enzyme known to excise uracil from DNA with a high
turnover rate (4); SMUG1 was ®rst described as a single-
strand-selective UDG (21), but was then shown to process
G´U, A´U, A´HmU and G´HmU substrates too (22,23); MBD4,
which is related to bacterial EndoIII-type DNA glycosylases
and contains a methyl-CpG-binding domain, excises thymine
and uracil from G´T and G´U mismatches, respectively, but
also FU and eC when paired with guanine (24,25). It is dif®cult
to assess the signi®cance of these apparent functional overlaps
at this point, but it is likely that each of these enzymes evolved
to ful®ll specialized functions that are temporally and/or
spatially separated from each other in the cellular context. For
instance, the nuclear form of human UNG (UNG2) was shown
to co-localize with proliferating cell nuclear antigen (PCNA)
and replication protein A (RPA) in replication foci (26). No
such localization was found for SMUG1 (23) and TDG (our
unpublished data). ung±/± knockout mice do not exhibit an
increased spontaneous mutation frequency, most probably
because some uracil-processing activity remains in these cells
(27). In tissue extracts of ung±/± mice, this activity processes
G´U and less ef®ciently U opposite A or in ssDNA and can be
partly attributed to the SMUG1 enzyme (22). Thus, UNG2
may have evolved as a uracil-processing enzyme with a
specialized role in the elimination of dUMP misincorporated
opposite adenine during DNA synthesis, whereas the muta-
genic G´U mispairs resulting from cytosine deamination may
be repaired preferentially by one of the other uracil-excising
activities in the cell (SMUG1, TDG or MBD4). Considering
G´T repair in mammalian cells, TDG may associate with and
be active in transcribed regions of the genome through its
interaction with transcription factors (28±30), whereas MBD4
could be targeted to transcriptionally silent genomic regions
with dense CpG methylation through its methylated DNA-
binding domain (24,31). Finally, the MUG homologs in
general may play an additional role in repairing other
pyrimidine damage including eC, HU and HmU, and possibly
purine damage such as eA or Hx.
We conclude that MUG proteins form part of a DNA repair
network consisting of base damage recognition functions with
overlapping substrate speci®cities. Our data suggest that the
catalytic properties of individual members of the MUG
subfamily of UDGs have evolved in a species-speci®c manner.
TDG, Thp1p and Thd1p are thus illustrative examples of how
nature can take advantage of a simple but versatile catalytic
polypeptide to develop specialized enzymes by the addition of
activity-modulating extra domains. It is our hope that the study
of these enzymes in organisms easily amenable to genetic
manipulation will allow us to discover their true biological
role.
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